Relationship between abnormal P-wave terminal force in lead V₁ and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study

References

• Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164:2126–34.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Castelli WP, McNamara PM, et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972;287:781–7.
   PubMed Web of Science ®Google Scholar
• Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–52.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Bella JN, Rokkedal J, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study. Circulation. 2002;105:1071–6.
   PubMed Web of Science ®Google Scholar
• Vaziri SM, Larson MG, Lauer MS, et al. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995;25:1155–60.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Oikarinen L, Palmieri V, et al. Losartan Intervention For Endpoint Reduction in Hypertension S. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739–43.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284–9.
   PubMed Web of Science ®Google Scholar
• Teo SG, Yang H, Chai P, et al. Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis. Eur J Echocardiogr. 2010;11:38–43.
   PubMed Web of Science ®Google Scholar
• Tarazi RC, Miller A, Frohlich ED, et al. Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation. 1966;34:818–22.
   PubMed Web of Science ®Google Scholar
• Chandraratna PA, Hodges M. Electrocardiographic evidence of left atrial hypertension in acute myocardial infarction. Circulation. 1973;47:493–8.
   PubMed Web of Science ®Google Scholar
• Miller DH, Eisenberg RR, Kligfield PD, et al. Electrocardiographic recognition of left atrial enlargement. J Electrocardiol. 1983;16:15–22.
   PubMed Web of Science ®Google Scholar
• Tsao CW, Josephson ME, Hauser TH, et al. Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:7.
   PubMed Web of Science ®Google Scholar
• Josephson ME, Kastor JA, Morganroth J. Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol. 1977;39:967–71.
   PubMed Web of Science ®Google Scholar
• Morris JJ, Jr., Estes EH, Jr., Whalen RE, et al. P-wave analysis in valvular heart disease. Circulation. 1964;29:242–52.
   PubMed Web of Science ®Google Scholar
• Kamel H, Soliman EZ, Heckbert SR, et al. P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis. Stroke. 2014;45:2786–8.
   PubMed Web of Science ®Google Scholar
• Li Q, Gu LD, Zhang C, et al. A predictive study of the dynamic development of the P-wave terminal force in lead V1 in the electrocardiogram in relation to long-term prognosis in non-ST-segment elevation acute coronary syndrome patients during hospitalization. Ann Noninvasive Electrocardiol. 2015;20:542–53.
   PubMed Web of Science ®Google Scholar
• Liu G, Tamura A, Torigoe K, et al. Abnormal P-wave terminal force in lead V1 is associated with cardiac death or hospitalization for heart failure in prior myocardial infarction. Heart Vessels. 2013;28:690–5.
   PubMed Web of Science ®Google Scholar
• Krepp JM, Lin F, Min JK, et al. Relationship of electrocardiographic left ventricular hypertrophy to the presence of diastolic dysfunction. Ann Noninvasive Electrocardiol. 2014;19:552–60.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Harris KE, et al. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med. 2007;147:311–9.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Devereux RB Kjeldsen SE. Group LS, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995–1003.
   PubMed Web of Science ®Google Scholar
• Bella JN, Palmieri V, Liu JE, et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension. 2001;38:424–8.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Bella JN, Liebson PR, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension. 2000;35:6–12.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Smith G, Gerdts E, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol. 2000;85:466–72.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Bella J, Boman K, et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Blood Press. 2001;10:74–82.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Chamber quantification writing G, American society of echocardiography's G, standards C, European association of E. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Monteduro C, et al. Changes in midwall systolic performance and cardiac hypertrophy reduction in hypertensive patients. J Hypertens. 2000;18:1651–6.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Okin PM, Boman K, et al. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. Am J Hypertens. 2012;25:678–83.
   PubMed Web of Science ®Google Scholar
• Tanoue MT, Kjeldsen SE, Devereux RB, et al. Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy. Blood Press. 2016;1–9. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Gerdts E, Lund-Johansen P, Omvik P. Factors influencing left ventricular mass in salt sensitive and salt resistant essential hypertensive patients. Blood Press. 1998;7:223–30.
   PubMedGoogle Scholar
• Hammond IW, Devereux RB, Alderman MH, et al. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12:996–1004.
   PubMed Web of Science ®Google Scholar
• Romhilt DW, Bove KE, Conradi S, et al. Morphologic significance of left atrial involvement. Am Heart J. 1972;83:322–7.
   PubMed Web of Science ®Google Scholar
• Jin L, Weisse AB, Hernandez F, et al. Significance of electrocardiographic isolated abnormal terminal P-wave force (left atrial abnormality). An echocardiographic and clinical correlation. Arch Intern Med. 1988;148:1545–9.
   PubMedGoogle Scholar
• Tereshchenko LG, Henrikson CA, Sotoodehnia N, et al. Electrocardiographic deep terminal negativity of the P wave in V1 and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) study. J Am Heart Assoc. 2014;3:e001387.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett Jr., JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–74.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Burke T, Krobot K, et al. Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. J Hum Hypertens. 2004;18:367–73.
   PubMed Web of Science ®Google Scholar